News Roche launches human model systems institute Swiss pharma Roche has today officially launched a new institute that will focus on the use of human model systems – in vitro replicas of human tissues and organs – for dr
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.